Tirzepatide New Drug Weight Loss Expected Approval Fda This Year

Tirzepatide is a gastric inhibitory polypeptide (gip) analog and a glp-1 receptor agonist. [10] the most common side effects include nausea, vomiting, diarrhea, decreased appetite,. This site provides information about mounjaro ® (tirzepatide) and zepbound ® (tirzepatide), our prescription-only, fda-approved medicines containing tirzepatide.

It works by helping the pancreas to release the right amount of insulin when blood sugar levels are high. Mounjaro (tirzepatide) helps manage blood sugar in people with type 2 diabetes. It also helps with weight loss. It's an injection you take once every seven days.